Physician-prescribed compounded GHK-Cu topical formulations are generally less expensive per month than injectable programs
As of 1 January 2021, M2.2 (Intravenous infusions and/or injections of more than a total of 100 mL per 12-hour period) have now been classified as a Specified Method based on the newly introduced Article 4.2.2 in the 2021 Code, that makes it possible to identify a Prohibited Method as Specified
This should be the primary choice when repair matters more than wrinkle correction
3rd Floor, 1655, 27th Main Rd, opp
As an endogenous human tripeptide used topically for decades in skincare, GHK-Cu is generally regarded as well tolerated, with the most common issues being local irritation, redness, or contact sensitivity in susceptible individuals
Arch Pharm Res 32(1):109115 Paul B, Li Y, Tollefsbol T (2018) The effects of combinatorial genistein and sulforaphane in breast tumor inhibition: role in epigenetic regulation